PeptideSkincare
Peptide Science

Do Peptides Absorb Into Skin? What Penetration Studies Show

By · Published October 10, 2026 · 12 min read

Start with our pillar guide: Peptide Ingredients in Skincare: Signal, Carrier, Neurotransmitter and Enzyme-Inhibitor Peptides Explained, or browse all Peptide Science articles.

Direct answer: Do peptides absorb into skin? Some do, but most don't get far. Cosmetic peptides are large, water-loving molecules, and the skin's outer layer keeps such molecules out. In the one in vivo human study, a Matrixyl 3000 serum stayed in the outermost layer. Microneedles and chemical changes increase delivery. Evidence: early / preliminary.

Key takeaways

  • A 2022 review concluded that most anti-wrinkle peptides "might not reach their targets in the skin at right concentrations" unless their delivery is enhanced (Mortazavi & Moghimi, 2022).
  • Through intact human skin, almost no GHK-Cu peptide got through in 9 hours. After microneedle pretreatment, measurable amounts did (Li et al., 2015).
  • In 3 women, Matrixyl 3000 peptides reached every layer of the stratum corneum. That is still the skin's surface, not the dermis where collagen is made (Trzaska et al., 2026).
  • Palmitoylation, special emulsions and microneedles improve penetration in lab models. How much of that turns into visible results in people hasn't been measured.
  • Injecting peptides is a separate route, and there are no published human safety or efficacy data for it.

A question that comes up again and again in skincare forums goes roughly like this: aren't peptide molecules simply too big to get through skin? And if they are, am I paying for something that just sits on top? That's a fair thing to ask, and most product pages skip it. Our complete guide to peptide ingredients covers what each peptide is supposed to do. This article covers the step that comes before any of that: whether the molecule gets to where it would need to work.

The answer depends on the peptide, the formula and what you mean by "absorb." Below we go through the measured data for the 3 most-used peptide families: copper peptides like GHK-Cu, Matrixyl and Argireline. If you're choosing between the first 2, our Matrixyl vs. copper peptides comparison puts them head to head.

Why don't most peptides absorb into skin?

Your outermost skin layer, the stratum corneum, is a wall of flattened dead cells set in fatty lipids. It lets small, fat-soluble molecules through far more easily than large, water-soluble ones.

A 2022 review in the International Journal of Cosmetic Science lists 4 problems that peptides share (Mortazavi & Moghimi, 2022):

  • High molecular weight. Peptides are chains of amino acids, and even short chains are bulky compared with molecules that penetrate skin well.
  • Hydrophilicity. Most peptides dissolve in water rather than fat, so the lipid barrier pushes them back.
  • Ionizable groups. Charged parts of the molecule make crossing the lipids harder still.
  • Proteases. Skin contains enzymes that break down proteins, and they can cut peptides apart.

The authors argue that most anti-wrinkle peptides have to penetrate deep to work, and that "without the ability to permeate the skin sufficiently, this efficacy is useless." Their conclusion is that most peptides are not good candidates for passive skin permeation. Evidence: review of lab data.

GHK-Cu shows how strong the water-loving problem can be. Its log D, a measure of how a molecule splits between fat and water, was -2.38 to -2.49 across pH 4.5 to 7.4 (Badenhorst et al., 2016). A negative value means it strongly prefers water. The same study found GHK-Cu stable for 2 weeks at 60 °C in pH 4.5 to 7.4 buffers, but it broke down under basic and oxidative stress. Evidence: lab only.

Do peptides absorb into skin? What the penetration studies measured

GHK-Cu: the copper gets through more easily than the peptide

Older data looked encouraging. Researchers applied a 0.68% aqueous copper tripeptide solution to human skin in vitro using an "infinite dose," meaning far more product than you'd ever apply. About 136 µg/cm² of copper permeated over 48 hours, and 97 µg/cm² stayed in the skin (Hostynek et al., 2011). Two caveats: the skin was dermatomed (sliced thin), and the study measured copper, not the intact peptide. Number of skin donors and funding were not reported in the abstract. Evidence: lab only.

A later study tracked both parts separately. Through intact human skin, "almost no peptide or copper permeated" over 9 hours. After pretreating the skin with microneedles, 134 nmol of peptide and 705 nmol of copper got through (Li et al., 2015). Sample size and funder were not reported in the abstract. Evidence: lab only.

So "copper permeates skin" and "GHK-Cu permeates skin" are not the same claim. A 2025 review also describes GHK-Cu as hydrophilic, with limited stratum corneum permeation (Ogórek et al., 2025).

Matrixyl 3000: present throughout the stratum corneum, not inside the cells

The only in vivo human penetration data in our source set comes from a 2026 study by University of Nottingham researchers and employees of No7/Boots, a skincare brand (Trzaska et al., 2026; n=3, no citations yet). They applied a Matrixyl 3000 serum, which contains palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR), to 3 healthy women for 0.5, 2 or 5 hours.

Both peptides showed up in every layer of the stratum corneum, with less at greater depth. Leaving the serum on longer made no significant difference. The peptides sat on the outer surfaces of the cells, in the spaces between them, and not inside the corneocytes (the dead cells that make up the layer). Evidence: early / preliminary (n=3, brand-affiliated authors).

That's real evidence that a commercial peptide formula gets into skin. It's also evidence about the surface layer only. The study didn't measure the living epidermis or dermis.

Argireline: the formula matters, and the target may be out of reach

Argireline (acetyl hexapeptide-8) is marketed as a topical alternative to neurotoxins. It's thought to work by interfering with the nerve signal that makes muscles contract. Its permeation is poor because of its size, its water solubility and its zwitterionic form, meaning it carries both positive and negative charges (Lim et al., 2018). That team made modified versions, called Arg2 and Arg3, which permeated human skin better in vitro. Evidence: lab only.

The vehicle also matters. In pig skin, a water-in-oil-in-water multiple emulsion increased acetyl hexapeptide-8 penetration significantly compared with standard oil-in-water and water-in-oil creams. Water-rich emulsions beat oil-rich ones (Hoppel et al., 2015). Evidence: lab / animal only.

The bigger question is whether Argireline reaches the muscle at all. A 2025 review says that "the ability of AH-8 to reach neuromuscular junctions remains uncertain" (Zdrada-Nowak et al., 2025). Those junctions sit much deeper than the stratum corneum.

What that means for real-world results is covered in what Argireline does.

The most direct measurement comes from US FDA scientists. They applied an oil-in-water cream with 10% acetyl hexapeptide-8 to human cadaver skin for 24 hours. Most of it washed off the surface. Only 0.22% of the applied dose was found in the stratum corneum and 0.01% in the epidermis, and none was detected in the dermis or the fluid beneath the skin (Kraeling et al., 2015). Evidence: lab only. That is one formula in dead skin, but it is the clearest data point against a muscle-level effect from an ordinary cream.

Do skin enzymes destroy peptides first?

Not always, at least in the lab. In a skin homogenate assay (ground-up skin tissue used to test enzyme breakdown), palmitoyl pentapeptide-4 (pal-KTTKS, the original Matrixyl) and 2 new peptides stayed stable against proteases for up to 8 hours (Errante et al., 2021). One author worked part-time for Espikem, a peptide company. A homogenate isn't living skin, so treat this as a sign that some peptides can survive. It doesn't show that all of them do. Evidence: lab only.

Does absorbing into the stratum corneum mean a peptide reaches the dermis?

The gap between the stratum corneum and the dermis is the one marketing language tends to blur. The stratum corneum is the dead outer layer. Below it is the living epidermis, and below that is the dermis, where fibroblasts make collagen.

Peptides like GHK-Cu and Matrixyl are signal peptides, one of the 4 classes in a widely cited review along with carrier, neurotransmitter-inhibiting and enzyme-inhibitor peptides (Gorouhi & Maibach, 2009). The theory is that they tell fibroblasts to make more collagen, so they need to reach fibroblasts. A study that finds a peptide "throughout the stratum corneum" is reporting the first step of that trip, not the last.

When a brand says its peptide "penetrates the skin," ask which layer, which measurement and whose skin. Often the answer is the stratum corneum, in a lab model.

Do delivery tricks actually help?

The 2022 review lists the approaches researchers have tried: adding fat-soluble groups, attaching cell-penetrating peptides, metal complexation (binding to a metal like copper), chemical penetration enhancers, iontophoresis (a weak electric current), microneedles and nanocarriers. These approaches increased permeability for carnosine, GHK, PKEK, GEKG, GQPR and KTTKS (Mortazavi & Moghimi, 2022). A 2023 review covers similar passive and active strategies for peptide nanoformulations (Zhang et al., 2023).

Palmitoylation. "Palmitoyl" on a label means a fatty acid has been attached to make the peptide more fat-soluble. A 2025 review of GHK says both palmitoylation and copper complexation increase permeability (Mortazavi et al., 2025). This is the most common upgrade you'll see in products. Evidence: lab only for permeability.

Liposomes and encapsulation. Liposomes are tiny fat bubbles that can carry a payload. They're used heavily in marketing, but a 2025 review notes that skin transport of liposome-encapsulated GHK-Cu has "received little attention" (Ogórek et al., 2025). "Liposomal" on a label is a formulation choice. It isn't proof of deeper delivery.

Microneedles. These have the strongest measured effect on intact peptide delivery in our sources (see the Li data above). The 2025 GHK review also calls them promising (Mortazavi et al., 2025). Clinic microneedling is a different setting from a lab pretreatment, though. Applying products to freshly needled skin also raises irritation and contamination questions, which belong with your treating clinician.

If peptides barely absorb into skin, why do some trials show results?

A small amount may be enough, and some effects may come from the outer layer or the moisturizing base. Most positive trials are small or industry-funded.

Poor penetration doesn't mean zero penetration, and a small amount may be enough for some peptides. In a 12-week, double-blind, randomized split-face trial of 93 women aged 35 to 55, a moisturizer with 3 ppm palmitoyl pentapeptide-4 improved wrinkles and fine lines significantly compared with placebo. The trial was funded by P&G, the product's manufacturer (Robinson et al., 2005). A smaller 8-week RCT of 21 women found palmitoyl pentapeptide-4 beat both a comparator peptide and placebo on crow's feet. Its authors called it an initial study (Aruan et al., 2023). Evidence: limited.

GHK-Cu is weaker on this point. The 2025 review describes a "surprising absence of clinical studies" for GHK-Cu and Pal-GHK in the indexed literature (Mortazavi et al., 2025; a narrative review with about 12 citations so far. Evidence: limited.). Small industry-funded topical trials have been described elsewhere, but published, peer-reviewed human trials are scarce.

Is injecting peptides a way around poor absorption?

No. Injecting cosmetic peptides is untested in published human studies and carries safety risks, especially with grey-market products.

Because creams struggle to get through, some people now inject GHK-Cu under the skin, often buying it from grey-market online sellers. NPR reported in September 2026 that "there is no data from published human studies to show this practice is safe and effective," and that GHK-Cu is not an approved drug (NPR, 2026). Experts quoted raised concerns about copper overload, immune reactions and whether the vials even contain what the label says. One clinician reported injection-site irritation, infections and elevated liver enzymes in people who self-inject, though the cause was unclear. We don't recommend this route. Talk to a clinician before considering any injectable.

What does peptide absorption mean when you shop?

Expect modest, surface-level effects. Formulation details matter more than the peptide name on the front of the bottle.

  • Look for formulation details, not just the peptide name. Palmitoylated peptides and copper complexes have better lab permeability data than bare peptides.
  • Treat "penetrates deep" claims skeptically unless the brand names the study and the skin layer it measured.
  • Don't pay extra for "liposomal" alone. The transport data for liposomal GHK-Cu is thin.
  • Favor leave-on serums and moisturizers over rinse-off products. In the Trzaska study, peptides were found in skin after 30 minutes. A cleanser is on your face for seconds.
  • Check the ingredient names in the EU's CosIng database. It lists copper tripeptide-1, palmitoyl pentapeptide-4, palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7 as skin-conditioning ingredients, which is a cosmetic category, not a drug category.

Where the evidence stops

  • Almost no in vivo human data. The one in vivo study had 3 participants and measured the stratum corneum only.
  • No dermis measurements in people. We found no human study showing how much intact peptide reaches fibroblasts after normal topical use.
  • Unknown effective dose. Nobody has shown how much peptide needs to reach the dermis to change collagen in people.
  • Lab conditions are generous. Infinite doses, thinned skin and pig skin all differ from a thin layer of serum on your face.
  • Liposomes are understudied, and real-world microneedling with peptides hasn't been tested in controlled trials in our sources.

FAQ

Are peptide molecules too big to get through skin? Size is one of 4 barriers, along with water solubility, charge and skin enzymes (Mortazavi & Moghimi, 2022). Most peptides penetrate poorly, but not none at all. Modified peptides, like palmitoylated ones, do better in lab tests.

Am I paying for a peptide that just sits on the surface? Partly. In 3 women, Matrixyl 3000 peptides spread through the whole stratum corneum but weren't measured deeper (Trzaska et al., 2026). Whether enough reaches living skin to matter is unknown for most products.

Does palmitoylation make peptides absorb better? In lab studies, yes. Adding a fatty acid increases GHK's permeability (Mortazavi et al., 2025). Human data on how far palmitoylated peptides travel is limited to the stratum corneum.

Do liposomal or encapsulated peptides penetrate deeper? They might, but the data is thin. A 2025 review says skin transport of liposomal GHK-Cu has received little attention (Ogórek et al., 2025).

Should I use peptides after microneedling? Microneedle pretreatment greatly increased GHK-Cu delivery in a lab study (Li et al., 2015). Freshly needled skin is more vulnerable to irritation and infection, though. Ask the clinician performing the treatment what's safe to apply.

If peptides don't absorb well, why do some trials show results? Low penetration isn't zero, and a small amount may be enough. A 93-person, P&G-funded split-face trial found palmitoyl pentapeptide-4 improved wrinkles over 12 weeks (Robinson et al., 2005). Independent replication is limited.

References

  1. Mortazavi SM, Moghimi HR. Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. Int J Cosmet Sci. 2022. Review. https://pubmed.ncbi.nlm.nih.gov/35302659/
  2. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. GHK review. Bioimpacts. 2025. Review; no conflicts of interest declared. https://pubmed.ncbi.nlm.nih.gov/39963574/
  3. Badenhorst T, et al. GHK-Cu physicochemical properties and stability. Pharm Dev Technol. 2016. In vitro. https://pubmed.ncbi.nlm.nih.gov/25384620/
  4. Hostynek JJ, Dreher F, Maibach HI. Copper tripeptide permeation of human skin. Inflamm Res. 2011. In vitro human skin; measured copper; n not reported in the abstract. https://pubmed.ncbi.nlm.nih.gov/20721598/
  5. Li H, et al. GHK-Cu permeation through intact and microneedle-treated human skin. Pharm Res. 2015. In vitro human skin; n not reported in the abstract. https://pubmed.ncbi.nlm.nih.gov/25690343/
  6. Trzaska AH, et al. In vivo stratum corneum penetration of Matrixyl 3000 peptides. Int J Pharm. 2026. In vivo, n=3, 0.5–5 h; authors include No7/Boots employees. https://pubmed.ncbi.nlm.nih.gov/42790608/
  7. Hoppel M, et al. Acetyl hexapeptide-8 penetration from different emulsion types. Eur J Pharm Sci. 2015. Porcine skin, in vitro. https://pubmed.ncbi.nlm.nih.gov/25497319/
  8. Lim SH, et al. Modified Argireline analogues with improved skin permeation. Sci Rep. 2018. In vitro human skin. https://pubmed.ncbi.nlm.nih.gov/29371611/
  9. Zdrada-Nowak J, et al. Acetyl hexapeptide-8 review. Int J Mol Sci. 2025. Review. https://pubmed.ncbi.nlm.nih.gov/40565185/
  10. Errante F, et al. Protease stability of cosmetic peptides in skin homogenate. J Pharm Biomed Anal. 2021. In vitro; one author part-time at Espikem. https://pubmed.ncbi.nlm.nih.gov/33281001/
  11. Ogórek K, et al. GHK-Cu review. Molecules. 2025. Review. https://pubmed.ncbi.nlm.nih.gov/39795193/
  12. Zhang T, et al. Peptide nanoformulations and skin penetration enhancement. Adv Drug Deliv Rev. 2023. Review. https://pubmed.ncbi.nlm.nih.gov/37951358/
  13. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009. Review. https://pubmed.ncbi.nlm.nih.gov/19570099/
  14. Robinson LR, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005. Randomized double-blind placebo-controlled split-face, n=93, 12 weeks; P&G-funded. https://pubmed.ncbi.nlm.nih.gov/18492182/
  15. Aruan RR, et al. AHP-3 vs palmitoyl pentapeptide-4 vs placebo for crow's feet. J Clin Aesthet Dermatol. 2023. Double-blind RCT, n=21, 8 weeks; no conflicts of interest declared. https://pubmed.ncbi.nlm.nih.gov/36909866/
  16. Kraeling ME, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015. In vitro, human cadaver and hairless guinea pig skin, 10% O/W emulsion, 24 h; US FDA authors. https://pubmed.ncbi.nlm.nih.gov/24754410/
  17. Stone W. The copper peptide trend has gone from creams to injections — ahead of the science. NPR Morning Edition. September 7, 2026. News report, not efficacy evidence. https://www.npr.org/2026/09/07/nx-s1-5955552/copper-peptides-skin-aging-health-safe

Disclosure: This article is for general education and isn't medical advice. It doesn't replace a consultation with a dermatologist or other qualified clinician, especially before procedures like microneedling or any injectable product. This article contains no affiliate links. Peptide Skincare Editorial Team articles follow our evidence and citation standards.

For educational purposes only; not medical advice. See our disclaimer and research method.